KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash from Operations (2017 - 2025)

Twist Bioscience (TWST) has disclosed Cash from Operations for 9 consecutive years, with 24814000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 15.8% to 24814000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 51014000.0 through Dec 2025, up 18.44% year-over-year, with the annual reading at 47628000.0 for FY2025, 25.69% up from the prior year.
  • Cash from Operations for Q4 2025 was 24814000.0 at Twist Bioscience, down from 11814000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 1267000.0 in Q3 2022, with the low at 54070000.0 in Q4 2022.
  • Average Cash from Operations over 5 years is 24535350.0, with a median of 23192500.0 recorded in 2023.
  • The sharpest move saw Cash from Operations surged 96.36% in 2022, then crashed 1534.1% in 2023.
  • Over 5 years, Cash from Operations stood at 46653000.0 in 2021, then dropped by 15.9% to 54070000.0 in 2022, then skyrocketed by 57.51% to 22973000.0 in 2023, then increased by 6.73% to 21428000.0 in 2024, then dropped by 15.8% to 24814000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 24814000.0, 11814000.0, and 1400000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.